Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15246265rdf:typepubmed:Citationlld:pubmed
pubmed-article:15246265lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:15246265lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:15246265lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:15246265lifeskim:mentionsumls-concept:C0598312lld:lifeskim
pubmed-article:15246265lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:15246265pubmed:issue2lld:pubmed
pubmed-article:15246265pubmed:dateCreated2004-7-12lld:pubmed
pubmed-article:15246265pubmed:abstractTextWe investigated the effects of signaling through CD28 family molecules on human immunodeficiency virus type 1 (HIV-1) replication in vitro. A monoclonal antibody (mAb) specific for inducible costimulator (ICOS) suppressed both X4 and R5 HIV-1 replication in CD4(+) peripheral blood mononuclear cells (PBMC). This suppression was not attributable to reduced cell growth or viability. CD28 mAb showed variable effects and also suppressed HIV-1 replication when immobilized. Replication of pseudotype viruses with HIV-1-but not with vesicular stomatitis virus G-envelope was efficiently suppressed in CD4(+) PBMC treated with ICOS or CD28 mAbs. However, CD4, CXCR4, and CCR5 expression on the surface was not down-regulated. Moreover, HIV-1 replication in CD4(+) PBMC was suppressed by a soluble form of human B7-H2, a ligand of ICOS, but was enhanced by soluble B7-1, a ligand for CD28. These findings suggest that natural or artificial ligands for ICOS potentially suppress HIV-1 replication mainly at the entry stages.lld:pubmed
pubmed-article:15246265pubmed:languageenglld:pubmed
pubmed-article:15246265pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:citationSubsetIMlld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15246265pubmed:statusMEDLINElld:pubmed
pubmed-article:15246265pubmed:monthAuglld:pubmed
pubmed-article:15246265pubmed:issn0042-6822lld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:ZhouXinXlld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:OhashiTakashi...lld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:KannagiMariMlld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:AzumaMiyukiMlld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:MasudaTakaoTlld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:KuboMakotoMlld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:KuriharaKiyos...lld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:NishitsujiHir...lld:pubmed
pubmed-article:15246265pubmed:authorpubmed-author:IkedaTamakoTlld:pubmed
pubmed-article:15246265pubmed:issnTypePrintlld:pubmed
pubmed-article:15246265pubmed:day1lld:pubmed
pubmed-article:15246265pubmed:volume325lld:pubmed
pubmed-article:15246265pubmed:ownerNLMlld:pubmed
pubmed-article:15246265pubmed:authorsCompleteYlld:pubmed
pubmed-article:15246265pubmed:pagination252-63lld:pubmed
pubmed-article:15246265pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:meshHeadingpubmed-meshheading:15246265...lld:pubmed
pubmed-article:15246265pubmed:year2004lld:pubmed
pubmed-article:15246265pubmed:articleTitleInducible-costimulator-mediated suppression of human immunodeficiency virus type 1 replication in CD4(+) T lymphocytes.lld:pubmed
pubmed-article:15246265pubmed:affiliationDepartment of Immunotherapeutics, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.lld:pubmed
pubmed-article:15246265pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15246265pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:15246265pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed